EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号？ 提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠方向;肝病方向 经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下，这个杂志的要不要稿费啊，彩图多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向：biomarker;肝癌 经验分享：插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2022-02-01 白.

请问投稿后多久分配稿号？
提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗

71 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号？ 提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠方向;肝病方向 经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下，这个杂志的要不要稿费啊，彩图多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向：biomarker;肝癌 经验分享：插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2021-03-03 萧念

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：胃肠方向;肝病方向
经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。

112 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号？ 提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠方向;肝病方向 经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下，这个杂志的要不要稿费啊，彩图多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向：biomarker;肝癌 经验分享：插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2023-08-15 ms1000001347062777 来自北京

请问submit后多久分配稿号？已经7天了，还是submitted to journal

31 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号？ 提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠方向;肝病方向 经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下，这个杂志的要不要稿费啊，彩图多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向：biomarker;肝癌 经验分享：插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2020-05-15 xxk7235

这个投稿后如果没有所有作者都确认，是不是就无法送审？

172 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号？ 提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠方向;肝病方向 经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下，这个杂志的要不要稿费啊，彩图多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向：biomarker;肝癌 经验分享：插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2022-07-30 099092753

偏重的研究方向：肝病方向
经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章

61 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号？ 提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠方向;肝病方向 经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下，这个杂志的要不要稿费啊，彩图多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向：biomarker;肝癌 经验分享：插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2015-07-25 seeyoutomorrow

请问一下，这个杂志的要不要稿费啊，彩图多少钱？

612 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号？ 提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠方向;肝病方向 经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下，这个杂志的要不要稿费啊，彩图多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向：biomarker;肝癌 经验分享：插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2023-09-22 ms6000001416279458 来自湖北省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肝病方向
经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审

36 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号？ 提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠方向;肝病方向 经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下，这个杂志的要不要稿费啊，彩图多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向：biomarker;肝癌 经验分享：插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2018-12-09 fzdndx

审稿速度:1.0 | 投稿命中率:50.0
经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。

256 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号？ 提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠方向;肝病方向 经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下，这个杂志的要不要稿费啊，彩图多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向：biomarker;肝癌 经验分享：插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2019-12-06 147a1e7dm81(暂无昵称)

您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表:
original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。

leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。

164 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1189587, encodeId=c8ae118958e30, content=请问投稿后多久分配稿号？ 提交了大概5天了，所有作者也都确认了，但是一直没有分配稿号，各位老师知道是什么原因吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Tue Feb 01 20:44:00 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：胃肠方向;肝病方向 经验分享：这个杂志感觉投稿相对容易，比较容易中，可能是需要idea有些创新就可以了，审稿周期很快，基本一般是一个月左右，但是貌似接受后见刊时间比较长，因此，需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152824, encodeId=030b2152824c3, content=请问submit后多久分配稿号？已经7天了，还是submitted to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08408597435, createdName=ms1000001347062777, createdTime=Tue Aug 15 09:43:20 CST 2023, time=2023-08-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认，是不是就无法送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235698, encodeId=7cb012356981f, content=偏重的研究方向：肝病方向 经验分享：投稿两周多，直接录用，临床脂肪肝横断面研究文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7baa2132801, createdName=099092753, createdTime=Sat Jul 30 21:54:27 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下，这个杂志的要不要稿费啊，彩图多少钱？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=612, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159199, encodeId=038a2159199f6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝病方向 经验分享：6月29投稿的，8月11让修改，提了一条主要意见，感觉编辑措辞还是很温和的，然后我9月15再次提交，21号就接收了，还是蛮快的，我另一篇文章三个多月了还在一审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8a45634000, createdName=ms6000001416279458, createdTime=Fri Sep 22 22:00:49 CST 2023, time=2023-09-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=564228, encodeId=a4d056422813, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：临床肝病方向，投稿6次，秒拒3次，3次外审，不到一个月修回，而后顺利接收。总体上，难度不大，但对文章的创新性也有一点要求。语言要求不高。编辑还是很友好的，而且貌似愿意选择推荐的审稿人，哪怕推荐的是中国人。一般两个审稿人，有一次只有一个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6467517, createdName=fzdndx, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581039, encodeId=446f581039a4, content=您好，请问copyright那个表格在哪里下载？能不能发我一份？需要全部签字上传么，谢谢。leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, beContent=leook555 2019-08-26 16:49:00 发表: original article临床治疗方向，5月底投稿，第二天状态变成Under review，然后状态一直持续了2个月，中间写信催稿，主编说在审稿中，让再等等。8月17号突然收到拒稿，理由是审稿人未发回审稿意见。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5dfd5232144, createdName=147a1e7dm81(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241471, encodeId=c00d12414e139, content=偏重的研究方向：biomarker;肝癌 经验分享：插眼, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:36:54 CST 2022, time=2022-08-28, status=1, ipAttribution=)]

2022-08-28 Doctor小雷

偏重的研究方向：biomarker;肝癌
经验分享：插眼

61 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务